AR075496A1 - Proceso para la preparacion de compuestos opticamente activos usando hidrogenacion de transferencia y uso de los mismos - Google Patents

Proceso para la preparacion de compuestos opticamente activos usando hidrogenacion de transferencia y uso de los mismos

Info

Publication number
AR075496A1
AR075496A1 ARP090105061A ARP090105061A AR075496A1 AR 075496 A1 AR075496 A1 AR 075496A1 AR P090105061 A ARP090105061 A AR P090105061A AR P090105061 A ARP090105061 A AR P090105061A AR 075496 A1 AR075496 A1 AR 075496A1
Authority
AR
Argentina
Prior art keywords
preparation
catalytic reduction
asymmetric catalytic
optically active
active compounds
Prior art date
Application number
ARP090105061A
Other languages
English (en)
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40344210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR075496(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of AR075496A1 publication Critical patent/AR075496A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
    • C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/04—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups from amines with formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00—Asymmetric syntheses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/30—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reactions not involving the formation of esterified sulfo groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/001—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain
    • C07C37/002—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by modification in a side chain by transformation of a functional group, e.g. oxo, carboxyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/02—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with no unsaturation outside the aromatic ring
    • C07C39/11—Alkylated hydroxy benzenes containing also acyclically bound hydroxy groups, e.g. saligenol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Un proceso catalítico para la preparacion de compuestos opticamente activo y su conversion posteriormente hasta las sustancias de fármaco deseadas. En particular, el proceso se refiere a la preparacion del (S)-3-(1-dimetil-amino-etil)-fenol utilizando reduccion catalítica asimétrica e hidrogenacion de transferencia, proporcionando de esta manera una mejor ruta para la formacion de sustancias de fármaco, tales como rivastigmina y tartrato ácido de rivastigmina. Reivindicacion 1: Un proceso para la preparacion de un compuesto de acuerdo con la formula general (1) en donde: R1 = alquilo C1-20, alquenilo C2-20, alquinilo C2-20, haluro orgánico de 2 a 20 átomos de carbono, un arilo, un grupo amina o amida; y n =1 a 5; comprendiendo este proceso: (a) llevar a cabo una reduccion catalítica asimétrica sobre una hidroxifenona de acuerdo con la siguiente formula general (2) en donde: R1 = alquilo C1-20, alquenilo C2-20, alquinilo C2-20, haluro orgánico de 2 a 20 átomos de carbono, un arilo, un grupo que contiene amina o amida; n = 1 a 5; y en donde esta reduccion catalítica asimétrica se lleva a cabo utilizando hidrogenacion de transferencia, y en donde esta reduccion catalítica asimétrica se lleva a cabo utilizando un catalizador de metal quiral. Reivindicacion 33: El uso de un alcohol quiral preparado de acuerdo con cualquiera de las reivindicaciones 1 a 20, en la preparacion de un material de partida de un ingrediente farmacéutico activo para la produccion de composiciones farmacéuticas.
ARP090105061A 2008-12-24 2009-12-22 Proceso para la preparacion de compuestos opticamente activos usando hidrogenacion de transferencia y uso de los mismos AR075496A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0823554.1A GB0823554D0 (en) 2008-12-24 2008-12-24 Process for the preparation of optically active compounds using transfer hydrogenation

Publications (1)

Publication Number Publication Date
AR075496A1 true AR075496A1 (es) 2011-04-06

Family

ID=40344210

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090105061A AR075496A1 (es) 2008-12-24 2009-12-22 Proceso para la preparacion de compuestos opticamente activos usando hidrogenacion de transferencia y uso de los mismos

Country Status (22)

Country Link
US (2) US8415508B2 (es)
EP (1) EP2382172A1 (es)
JP (1) JP2012513966A (es)
KR (1) KR20110098964A (es)
CN (1) CN102264672A (es)
AR (1) AR075496A1 (es)
AU (1) AU2009331493B2 (es)
BR (1) BRPI0923394A2 (es)
CA (1) CA2748349A1 (es)
CL (1) CL2011001563A1 (es)
CO (1) CO6382153A2 (es)
EC (1) ECSP11011221A (es)
GB (1) GB0823554D0 (es)
IL (1) IL213520A0 (es)
MA (1) MA32983B1 (es)
MX (1) MX2011006918A (es)
MY (1) MY151103A (es)
NZ (1) NZ593493A (es)
SG (1) SG172052A1 (es)
TN (1) TN2011000290A1 (es)
TW (1) TW201035028A (es)
WO (1) WO2010072798A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103193600B (zh) * 2012-01-07 2016-04-06 浙江九洲药物科技有限公司 卡巴拉汀中间体的制备方法
CN105246873A (zh) * 2013-06-14 2016-01-13 日产化学工业株式会社 光学活性醇化合物的制造方法
CN103980270A (zh) * 2014-05-19 2014-08-13 埃斯特维华义制药有限公司 一种（r）-3-奎宁醇的制备方法
CN108752322A (zh) * 2018-09-12 2018-11-06 广州新民培林医药科技有限公司 一种新型Tepotinib衍生物和制备方法及其在抗肿瘤药物中的应用
CN109809967B (zh) * 2019-03-04 2022-03-18 陕西师范大学 一种合成手性醇的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201906B (en) 1987-03-04 1991-01-28 Sandoz Ag Process for producing phenyl-carbamate derivative and acid additional salts and pharmaceutical compositions containing them
US4996235A (en) * 1987-11-25 1991-02-26 Eli Lilly And Company 3,4-diphenylbutanamines
JPH0899940A (ja) * 1994-09-30 1996-04-16 Kanegafuchi Chem Ind Co Ltd 光学活性な１−（３，４−ジメトキシフェニル）−２−アミノプロパンの製造法
GB9706321D0 (en) 1997-03-26 1997-05-14 Zeneca Ltd Catalytic hydrogenation
JP3938651B2 (ja) * 2000-04-13 2007-06-27 セントラル硝子株式会社 光学活性α−メチル−ビス−３、５−（トリフルオロメチル）ベンジルアミンの製造方法
EP1346972A4 (en) 2000-12-25 2005-06-01 Ajinomoto Kk PROCESS FOR PREPARING OPTICALLY ACTIVE HALOHYDRIN COMPOUND
ATE414053T1 (de) * 2003-07-08 2008-11-15 Unilever Nv Verfahren zur herstellung einer kosmetisch aktiven verbindung
GB0329284D0 (en) 2003-12-18 2004-01-21 Avecia Ltd Process
KR101085804B1 (ko) * 2004-03-29 2011-11-22 간토 가가꾸 가부시키가이샤 광학 활성 알코올의 제법
US6939981B1 (en) * 2004-06-25 2005-09-06 Eastman Chemical Company Ruthenium complexes of phosphine-aminophosphine ligands
EP1856036B1 (en) * 2004-11-08 2016-12-14 Emcure Pharmaceuticals Limited An efficient method for preparation of (s)-3-[(1-dimethyl amino)ethyl]-phenyl-n-ethyl-n-methyl-carbamate
WO2006137167A1 (ja) 2005-06-20 2006-12-28 Kanto Kagaku Kabushiki Kaisha スルホナート触媒及びそれを利用したアルコール化合物の製法
TWI389709B (zh) 2005-12-01 2013-03-21 Novartis Ag 經皮治療系統
WO2007147897A1 (de) 2006-06-23 2007-12-27 Basf Se Verfahren zur herstellung von optisch aktiven 2-halogen-1-phenylethanol-derivaten und folgeprodukten davon
CA2760386A1 (en) 2008-05-01 2009-11-05 Kanata Chemical Technologies Inc. Cationic transition-metal arene catalysts

Also Published As

Publication number Publication date
WO2010072798A1 (en) 2010-07-01
JP2012513966A (ja) 2012-06-21
CO6382153A2 (es) 2012-02-15
MX2011006918A (es) 2011-07-29
US20100168229A1 (en) 2010-07-01
BRPI0923394A2 (pt) 2016-01-12
GB0823554D0 (en) 2009-01-28
SG172052A1 (en) 2011-07-28
AU2009331493A1 (en) 2011-07-07
IL213520A0 (en) 2011-07-31
TW201035028A (en) 2010-10-01
EP2382172A1 (en) 2011-11-02
CL2011001563A1 (es) 2012-01-13
US8415508B2 (en) 2013-04-09
ECSP11011221A (es) 2011-08-31
MA32983B1 (fr) 2012-01-02
CA2748349A1 (en) 2010-07-01
NZ593493A (en) 2013-03-28
KR20110098964A (ko) 2011-09-02
TN2011000290A1 (en) 2012-12-17
MY151103A (en) 2014-04-15
CN102264672A (zh) 2011-11-30
US20130096337A1 (en) 2013-04-18
AU2009331493B2 (en) 2013-03-07
US8637713B2 (en) 2014-01-28

Similar Documents

Publication Publication Date Title
CO6761397A2 (es) Métodos para preparar glicoesfingolípidos y usos de los mismos
PE20100487A1 (es) Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
AR075496A1 (es) Proceso para la preparacion de compuestos opticamente activos usando hidrogenacion de transferencia y uso de los mismos
PE20160788A1 (es) Procesos para preparar inhibidores de jak y compuestos intermediarios relacionados
UY31069A1 (es) Nuevos derivados de imidazoquinola, composiciones conteniendolos, proceso de preparacion y aplicaciones
UY32483A (es) Nuevos compuestos de bencimidazol para el tratamiento del virus sincicial respiratorio
UY29002A1 (es) Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia
ECSP10010620A (es) Derivados de indazol sustituidos con fenilo y benzodioxinilo
UY30824A1 (es) Nuevos derivados de idazolil éster o amida, composiciones farmacéuticas conteniéndolas, procesos de preparacion y aplicaciones.
UY33044A (es) Derivados del acido carbamoil-metil-amino-acetico sustituido como inhibidores de nep novedosos
UY33950A (es) Inhibidores de benzodioxano de la producciòn de leucotrieno
UY31524A1 (es) Nuevos compuestos 010
CO6300859A2 (es) Metodos para inhibidir las respuestas del etileno en plantas usando compuestos de cilpropeno amina
BR112012008485A2 (pt) composto, formulação farmacêutica, uso de um composto, processo para a fabricação do composto de formula e compostos, processos, formulações e usos
CL2008001783A1 (es) Acido desoxicolico (dca); composicion farmaceutica que lo comprende; procedimiento de preparacion de acido desoxicolico; compuestos intermediarios, utiles en la preparacion de un medicamento para remover depositos de grasa.
UY33485A (es) Derivados de acido(2-ariloxiacetilamino)fenilpropionico, procedimientos para su preparacion y uso de los mismos como medicamentos.
UY30808A1 (es) Derivados de benzotiazolonas, composiciones conteniéndolos y aplicaciones
UY29003A1 (es) Nuevos derivados de hidantoína, procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en terapia
UY28737A1 (es) Compuestos farmacéuticamente activos
AR079580A1 (es) Procesos para la fabricacion de un agente farmaceuticamente activo
CU20150058A7 (es) Derivados de imidazopiridazina como receptores de moduladores gabaa
AR116001A2 (es) Composición farmacéutica 271
ECSP067028A (es) Profármacos de esteroides con acción androgénica
AR074593A1 (es) Benzotiazol amidas para la deteccion del peptido beta amiloide
AR074721A1 (es) Derivados de 1,3 tiazol inhibidores de adn girasa y/o topoisomerasa iv

Legal Events

Date Code Title Description
FA Abandonment or withdrawal